Does Bristol Myers Squibb have a patient assistance program?
The Bristol Myers Squibb Patient Assistance Foundation (BMSPAF) is an independent, charitable organization that helps eligible patients who need temporary help obtaining the medicines listed on this website.
How is Opdivo administered?
OPDIVO is given through an intravenous (IV) infusion. The medicine is given directly into the bloodstream through a vein, usually in the arm or hand, by a healthcare professional. The infusion takes 30 minutes, though actual time in the clinic may vary. Your doctor will decide how many treatments are right for you.
How much does Opdivo and yervoy cost?
The combination of Yervoy (ipilumumab) and Opdivo (nivolumab) will cost more than $250,000 per year. Bristol-Myers Squibb is also testing the Yervoy/Opdivo combo for treatment of lung cancer.
What is Opdivo used for?
A drug that binds to the protein PD-1 to help immune cells kill cancer cells better and is used to treat many different types of cancer. These include cancers that express the protein PD-L1 or that have certain mutations (changes) in genes involved in DNA repair.
How long can you stay on Opdivo?
Your doctor will continue giving you OPDIVO for as long as you keep benefitting from it or until you no longer tolerate the treatment. Patients receiving OPDIVO after surgical removal of melanoma may require treatment for no longer than one year.
How quickly does Opdivo work?
How long does Opdivo take to work?Cancer Type (Trial name)Median Time to ResponseSquamous cell carcinoma of the head and neck (CheckMate-141)Opdivo: 2.1 months (range 1.8-7.4) vs Investigator's choice (methotrexate, docetaxel or cetuximab) : 2.0 (range 1.9-4.6)6 more rows
How much longer can you live with Opdivo and Yervoy?
With a minimum follow-up of 6.5 years, median overall survival (OS) was 72.1 months with Opdivo plus Yervoy (95% CI: 38.2-NR), the longest reported median OS in a Phase 3 advanced melanoma trial, 36.9 months with Opdivo (95% CI: 28.2-58.7) and 19.9 months with the Yervoy group (95% CI: 16.8-24.6).
What is cost of an Opdivo treatment?
The cost for Opdivo intravenous solution (10 mg/mL) is around $1,247 for a supply of 4 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
What are the most common side effects of Opdivo?
The most common side effects of OPDIVO, when used in combination with YERVOY and chemotherapy, include: feeling tired; pain in muscles, bones, and joints; nausea; diarrhea; rash; decreased appetite; constipation; and itching.
Is Opdivo well tolerated?
Opdivo and Yervoy are immunotherapy medications used to treat certain types of cancer. Opdivo and Yervoy can work together to better fight cancer by mobilizing your immune system. These medications are usually well-tolerated, but they can cause some serious side effects.
Is Opdivo better than chemotherapy?
Opdivo is the first PD-1 inhibitor to demonstrate superior OS and PFS in combination with chemotherapy when compared to chemotherapy alone in patients with gastric cancer, GEJ cancer or esophageal adenocarcinoma.
Is Opdivo expensive?
Depending on the dose, Opdivo can cost $6,580 per infusion. According to the manufacturer, more than 60 percent of patients pay only a quarter of this price or less with coverage from Medicare, Medicaid, or other insurance plans.
Is Opdivo well tolerated?
Opdivo and Yervoy are immunotherapy medications used to treat certain types of cancer. Opdivo and Yervoy can work together to better fight cancer by mobilizing your immune system. These medications are usually well-tolerated, but they can cause some serious side effects.
What are the most common side effects of Opdivo?
The most common side effects of OPDIVO, when used in combination with YERVOY and chemotherapy, include: feeling tired; pain in muscles, bones, and joints; nausea; diarrhea; rash; decreased appetite; constipation; and itching.
Is Opdivo better than chemotherapy?
Opdivo is the first PD-1 inhibitor to demonstrate superior OS and PFS in combination with chemotherapy when compared to chemotherapy alone in patients with gastric cancer, GEJ cancer or esophageal adenocarcinoma.
Is Opdivo a form of chemotherapy?
(IV) use. OPDIVO® (nivolumab) is a prescription medicine used in combination with chemotherapy that contains platinum and another chemotherapy medicine, before you have surgery, for adults with early-stage lung cancer (called non-small cell lung cancer).
What is OPDIVO in combination with?
OPDIVO, in combination with YERVOY ® (ipilimumab), is indicated for the treatment of patients with unresectable or metastatic melanoma.
What is OPDIVO used for?
OPDIVO is indicated for the adjuvant treatment of completely resected esophageal or gastroesophageal junction cancer with residual pathologic disease in patients who have received neoadjuvant chemoradiotherapy (CRT). OPDIVO, in combination with fluoropyrimidine- and platinum-containing chemotherapy, is indicated for the treatment ...
What is odivo in cancer?
OPDIVO ® (nivolumab), in combination with YERVOY ® (ipilimumab), is indicated for the treatment of adults and pediatric patients 12 years and older with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer (CRC) that has progressed following treatment with a fluoropyrimidine, oxaliplatin, and irinotecan. This indication is approved under accelerated approval based on overall response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.
What is opdivo nivolumab?
OPDIVO ® (nivolumab) is indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma who have disease progression during or following platinum-containing chemotherapy or have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy.
What is the name of the drug that is used to treat pleural mesothelioma?
OPDIVO ® (nivolumab), in combination with YERVOY ® (ipilimumab), is indicated for the first-line treatment of adult patients with unresectable malignant pleural mesothelioma (MPM).
What is nivolumab used for?
OPDIVO ® (nivolumab) is indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) with progression on or after platinum-based chemotherapy. Patients with EGFR or ALK genomic tumor aberrations should have disease progression on FDA-approved therapy for these aberrations prior to receiving OPDIVO.
Does opdivo cause liver toxicity?
OPDIVO in combination with cabozantinib can cause hepatic toxicity with higher frequencies of Grade 3 and 4 ALT and AST elevations compared to OPDIVO alone. Consider more frequent monitoring of liver enzymes as compared to when the drugs are administered as single agents. In patients receiving OPDIVO and cabozantinib, Grades 3 and 4 increased ALT or AST were seen in 11% of patients.
How much does Opdivo cost?
The cost for Opdivo intravenous solution (10 mg/mL) is around $1,189 for a supply of 4 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
What is Opdivo used for?
Opdivo (nivolumab) is a member of the anti-PD-1 monoclonal antibodies drug class and is commonly used for Colorectal Cancer, Esophageal Carcinoma, Head and Neck Cancer, and others.
How much does a free drug card save?
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Appeals Assistance
If the patient's insurer has denied coverage, the denial may be appealed. BMS Access Support may be able to assist by providing information about the appeals process.
Identification of Charitable Organizations
BMS Access Support may help to identify charitable organizations that may provide funding for eligible patients seeking financial assistance for prescription medication.
Available medicines
Find out if the medicine your doctor prescribed is available through the Bristol Myers Squibb Patient Assistance Foundation.
Eligibility
Complete a brief assessment to see if you might be eligible for assistance.
How to apply
We'll need some information from both you and your doctor to process your application.
